S. Tseleni-Balafouta

发表

Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.

I. Stamenkovic, N. Mitsiades, V. Poulaki, 2000, Cancer research.

Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

N. Mitsiades, C. Mitsiades, A. Ashkenazi, 2002, The American journal of pathology.

Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.

N. Mitsiades, C. Mitsiades, G. Voutsinas, 2009, Endocrine-related cancer.

Colorectal cancer metastases to the thyroid gland—a systematic review

D. Manatakis, S. Tseleni-Balafouta, D. Korkolis, 2020, Hormones.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

Joan W. Miller, N. Mitsiades, C. Mitsiades, 2005, Investigative ophthalmology & visual science.

Diagnostic Accuracy of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Detecting Occult Papillary Thyroid Microcarcinomas in Benign Multinodular Goitres

D. Manatakis, G. Sakorafas, S. Tseleni-Balafouta, 2018, Journal of thyroid research.

Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.

G. Chrousos, N. Mitsiades, V. Poulaki, 2000, Thyroid : official journal of the American Thyroid Association.

A comparative study of bone remodeling molecules expression in different types of jaw ameloblastoma.

A. Sklavounou, S. Tseleni-Balafouta, D. Vlachodimitropoulos, 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1998, The Journal of clinical endocrinology and metabolism.

Targeting BRAFV600E in thyroid carcinoma: therapeutic implications

D. McMillin, N. Mitsiades, C. Mitsiades, 2007, Molecular Cancer Therapeutics.

Cell senescence and a mechanism of clonal evolution leading to continuous cell proliferation, loss of heterozygosity, and tumor heterogeneity: studies on two immortal colon cancer cell lines.

S. Gagos, S. Tseleni-Balafouta, C. Antachopoulos, 1996, Cancer genetics and cytogenetics.

Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.

D. McMillin, N. Mitsiades, C. Mitsiades, 2006, The Journal of clinical endocrinology and metabolism.

Autoimmune thyroid disease in women with breast carcinoma.

C. Markopoulos, E. Kouskos, J. Gogas, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

An epitome of DNA repair related genes and mechanisms in thyroid carcinoma.

S. Theocharis, S. Tseleni-Balafouta, E. Gatzidou, 2010, Cancer letters.

Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation

D. McMillin, N. Mitsiades, C. Mitsiades, 2006, Clinical Cancer Research.

Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1999, The Journal of clinical endocrinology and metabolism.

Circulating thyroglobulin transcytosed by thyroid cells in complexed with secretory components of its endocytic receptor megalin.

L. Chiovato, S. Tseleni-Balafouta, F. Latrofa, 2000, The Journal of clinical endocrinology and metabolism.

Lessons learned from the management of Hungry Bone Syndrome following the removal of an Atypical Parathyroid Adenoma

S. Tseleni-Balafouta, P. Makras, D. Florakis, 2019, Journal of musculoskeletal & neuronal interactions.

Regulation of Vascular Endothelial Growth Factor Expression by Insulin-Like Growth Factor I in Thyroid Carcinomas

N. Mitsiades, C. Mitsiades, V. Poulaki, 2003 .

Pre-operative Tc-99m-Sestamibi Scanning and Intra-Operative Nuclear Mapping: Are they Accurate In Localizing Parathyroid Adenomas ?

H. Gogas, C. Markopoulos, E. Kouskos, 2003, Acta chirurgica Belgica.

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.

N. Mitsiades, C. Mitsiades, G. Voutsinas, 2006, The Journal of clinical endocrinology and metabolism.

Expression of OPG, RANKL, and Trail in Odontogenic Keratocysts (OKC): An Immunohistochemical Study

I. Koutlas, S. Tseleni-Balafouta, K. Tosios, 2007 .

Low-dose heparin treatment does not inhibit SW480 human colon cancer growth and metastasis in vivo.

S. Gagos, S. Tseleni-Balafouta, P. Karayannacos, 1996, In vivo.

Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma.

G. Voutsinas, E. Patsouris, S. Tseleni-Balafouta, 2006, Experimental and molecular pathology.

Expression of MMPs and TIMP-1 in smoker and nonsmoker chronic periodontitis patients before and after periodontal treatment.

S. Tseleni-Balafouta, S. Tseleni-Balafouta, G. Fanourakis, 2012, Journal of periodontal research.